New Rhein Healthcare Investors
Philadelphia, Pennsylvania, United StatesFounded 2010
New Rhein Healthcare Investors employs a private equity approach to life sciences venture capital, focusing on later-stage, de-risked assets with proven clinical safety and efficacy. Their strategy involves taking significant ownership stakes in a limited number of companies, actively managing value creation through operational support and strategic guidance, and prioritizing product development execution and strategic exits.
50% of their portfolio is in Healthcare. Their most common stage is series-c (50% of deals).
Portfolio
2
Fund Size
$145M
Top Stage
Series C
Last 12 Mo
0
Portfolio Breakdown
Stage Distribution
Sector Distribution
Portfolio
2 investments
| Company | Round | Amount | Date |
|---|---|---|---|
 Theranica | Series C | $45M | Aug 2022 |
 Chase Pharmaceuticals Corporation | Series B | $22M | — |
Top Co-Investors
Last updated: 28 April 2026